학술논문
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
Document Type
Article
Author
Source
Subject
*GENETIC vectors
*VACCINE safety
*INDUSTRIAL safety
*COVID-19 vaccines
*VACCINE development
*VIRAL vaccines
*VACCINES
*
*
*
*
*
*
Language
ISSN
0264-410X
Abstract
Several live-attenuated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of live-attenuated viral vaccines. This will help key stakeholders assess potential safety issues and understand the benefit-risk of such vaccines. The standardized and structured assessment provided by the template would also help to contribute to improved communication and support public acceptance of licensed live-attenuated viral vaccines. [ABSTRACT FROM AUTHOR]